Clinical trial
Fast Titration in the Treatment of Schizophrenia, Taiwan
NCT00304473 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00304473 |
|---|---|
| Title | Fast Titration in the Treatment of Schizophrenia, Taiwan |
| Official title | Fast Titration of Quetiapine Versus Conventional Titration in the Treatment of Schizophrenia/Schizoaffective Disorder: a Randomised, Parallel Group Open Trial |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Quetiapine fumarate |
| Enrollment | 40 |
| Start date | Aug 1, 2004 |
| Completion | Apr 1, 2006 |
| First posted | Mar 20, 2006 |
| Last update posted | Mar 25, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: